125 related articles for article (PubMed ID: 38267067)
1. Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ.
Schmidt MK; Lips EH; Schmitz RS; Verschuur E; Wesseling J
BMJ; 2024 Jan; 384():q22. PubMed ID: 38267067
[No Abstract] [Full Text] [Related]
2. Ductal carcinoma in situ of breast: detection and treatment pattern in Hong Kong.
Yau TK; Chan A; Cheung PS
Hong Kong Med J; 2017 Feb; 23(1):19-27. PubMed ID: 27779099
[TBL] [Abstract][Full Text] [Related]
3. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
[TBL] [Abstract][Full Text] [Related]
4. Active surveillance of women diagnosed with atypical ductal hyperplasia on core needle biopsy may spare many women potentially unnecessary surgery, but at the risk of undertreatment for a minority: 10-year surgical outcomes of 114 consecutive cases from a single center.
Farshid G; Edwards S; Kollias J; Gill PG
Mod Pathol; 2018 Mar; 31(3):395-405. PubMed ID: 29099502
[TBL] [Abstract][Full Text] [Related]
5. Intraductal proliferations of the breast: a review of histologic criteria for atypical intraductal hyperplasia and ductal carcinoma in situ, including apocrine and papillary lesions.
Purcell CA; Norris HJ
Ann Diagn Pathol; 1998 Apr; 2(2):135-45. PubMed ID: 9845731
[TBL] [Abstract][Full Text] [Related]
6. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for breast cancer mortality after ductal carcinoma in situ diagnosis differ from those for invasive recurrence.
O'Keefe TJ; Chau H; Harismendy O; Wallace AM
Surgery; 2023 Feb; 173(2):305-311. PubMed ID: 36435650
[TBL] [Abstract][Full Text] [Related]
8. Breast Ductal Carcinoma in Situ: Precursor to Invasive Breast Cancer.
Coleman WB
Am J Pathol; 2019 May; 189(5):942-945. PubMed ID: 31029232
[TBL] [Abstract][Full Text] [Related]
9. Patterns of aggressiveness: risk of progression to invasive breast cancer by mammographic features of calcifications in screen-detected ductal carcinoma in situ.
Lilleborge M; Falk RS; Hovda T; Holmen MM; Ursin G; Hofvind S
Acta Radiol; 2022 May; 63(5):586-595. PubMed ID: 33887963
[TBL] [Abstract][Full Text] [Related]
10. Management of screen detected ductal carcinoma in situ of the female breast.
Carpenter R; Boulter PS; Cooke T; Gibbs NM
Br J Surg; 1989 Jun; 76(6):564-7. PubMed ID: 2547496
[TBL] [Abstract][Full Text] [Related]
11. Tumor-infiltrating lymphocytes and ductal carcinoma in situ of the breast: friends or foes?
Agahozo MC; Hammerl D; Debets R; Kok M; van Deurzen CHM
Mod Pathol; 2018 Jul; 31(7):1012-1025. PubMed ID: 29463884
[TBL] [Abstract][Full Text] [Related]
12. The clinical significance of breast MRI in the management of ductal carcinoma in situ diagnosed on needle biopsy.
Miyashita M; Amano G; Ishida T; Tamaki K; Uchimura F; Ono T; Yajima M; Kuriya Y; Ohuchi N
Jpn J Clin Oncol; 2013 Jun; 43(6):654-63. PubMed ID: 23592884
[TBL] [Abstract][Full Text] [Related]
13. Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up.
Sanders ME; Schuyler PA; Simpson JF; Page DL; Dupont WD
Mod Pathol; 2015 May; 28(5):662-9. PubMed ID: 25502729
[TBL] [Abstract][Full Text] [Related]
14. The mammography screening detection of ductal carcinoma in situ and invasive breast cancer according to women's characteristics: is it the same?
Théberge I; Vandal N; Guertin MH; Perron L
Breast Cancer Res Treat; 2019 Apr; 174(2):525-535. PubMed ID: 30564969
[TBL] [Abstract][Full Text] [Related]
15. Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast.
Solin LJ; Fourquet A; McCormick B; Haffty B; Recht A; Schultz DJ; Barrett W; Fowble BL; Kuske R; Taylor M
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):3-9. PubMed ID: 8083125
[TBL] [Abstract][Full Text] [Related]
16. Current approach and future perspective for ductal carcinoma in situ of the breast.
Kanbayashi C; Iwata H
Jpn J Clin Oncol; 2017 Aug; 47(8):671-677. PubMed ID: 28486668
[TBL] [Abstract][Full Text] [Related]
17. Ductal carcinoma in situ of breast: update 2019.
Badve SS; Gökmen-Polar Y
Pathology; 2019 Oct; 51(6):563-569. PubMed ID: 31472981
[TBL] [Abstract][Full Text] [Related]
18. A case of male breast encapsulated papillary carcinoma with ductal carcinoma in situ and invasive ductal carcinoma.
Hong F; Li N; Feng Z; Zhang F
Asian J Surg; 2023 Sep; 46(9):3777-3778. PubMed ID: 36990811
[No Abstract] [Full Text] [Related]
19. Trends in incidence and tumour grade in screen-detected ductal carcinoma in situ and invasive breast cancer.
Luiten JD; Voogd AC; Luiten EJT; Duijm LEM
Breast Cancer Res Treat; 2017 Nov; 166(1):307-314. PubMed ID: 28748346
[TBL] [Abstract][Full Text] [Related]
20. Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.
Prescrire Int; 2013 Dec; 22(144):298-303. PubMed ID: 24600734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
